AGR3 has recently been described as up-regulated in breast cancer compared to normal breast tissues [25], while the putative clinical impact of AGR3 over-expression in breast cancer as prognostic or diagnostic protein biomarker remains elusive. The gene discussed is AGR3; the disease is breast cancer.